CRISPR Medicine News, 17 November 2020 | CRISPR-Cas Clinical Trial Update - CRISPR Medicine

CRISPR-Cas Clinical Trial Update

New clinical trials within gene editing are popping up all the time. Our latest clinical trials update includes 4 recently initiated trials, all using CRISPR-Cas technology to treat diseases including herpes simplex virus refractory keratitis, sickle cell disease, hereditary transthyretin amyloidosis or thalassemia genetic disease.

In these trials, CRISPR-Cas is either used directly to treat the condition by editing an individual's genome in vivo or indirectly through ex vivo engineering of a cell-based therapy.

Career CRISPR Medicine

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at We love hearing from readers!

Happy Reading!


p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.